Removing the Stigma of Medication for Opioid Use Disorder

Activity Preview

The national opioid crisis continues to be one of the most pressing public health issues in modern history. As the most accessible health care provider, pharmacists are positioned to play a leading role in the treatment of substance use disorder. Gaining a better understanding of how substance use disorder fits a disease state model and the true, evidence-based benefits of treatment will provide pharmacists the tools needed to help break the stigma and improve care to this patient population.

Learning Objectives

At the completion of this knowledg-based activity, the participant will be able to:

  1. Describe the stigma associated with substance use disorder
  2. Describe the neurobiology of substance use disorder
  3. Discuss the role and impact of pharmacotherapy for substance use disorder
  4. Discuss the benefits and misconceptions about naloxone
  5. Discuss strategies to improve access to buprenorphine

Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 1

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-247-H08-P.  

To obtain credit for Removing the Stigma of Medication for Opioid Use Disorder, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: October 1, 2020
Expiration date: October 1, 2023 - No credit can be earned after this date

Development

Removing the Stigma of Medication for Opioid Use Disorder is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association

Disclosures

Thomas Franko, PharmD, BCACPAnita N. Jacobson, PharmD, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-20-247-H08-P 0.2 CEUs October 01, 2020 - October 01, 2023